Skip to main content
Top
Published in: Rheumatology International 7/2008

01-05-2008 | Original Article

Definition of disease duration in ankylosing spondylitis

Authors: Ernst Feldtkeller, Jon Erlendsson

Published in: Rheumatology International | Issue 7/2008

Login to get access

Abstract

Two definitions of the “disease duration” of ankylosing spondylitis (AS) have been used in the literature: (1) duration since first symptoms connected with AS and (2) duration since diagnosis of AS. To investigate how useful these definitions are for research, we reinvestigated the data of four surveys completed by patients with AS in the years since 1996. We found that the majority of the patients remembered the age at first symptoms with an accuracy of ≤1 year, and that the difference between both definitions (the delay in diagnosis) was between 9.8 and 10.4 years on average, with extreme values of more than 30 years being not very seldom. Because the error made using the duration since diagnosis as “disease duration” is much larger than the inaccuracy taken into account using the duration since first symptoms, only the duration since first symptoms connected with AS should be used as definition for the term “disease duration” of AS.
Literature
1.
go back to reference Spoorenberg A, van der Heijde D, de Klerk E, Dougados M, de Vlam K, Mielants H, van der Tempel H, van der Linden S (1999) A comparative study of the usefulness of the Bath ankylosing spondylitis functional index and the Dougados functional index in the assessment of ankylosing spondylitis. J Rheumatol 26:961–965PubMed Spoorenberg A, van der Heijde D, de Klerk E, Dougados M, de Vlam K, Mielants H, van der Tempel H, van der Linden S (1999) A comparative study of the usefulness of the Bath ankylosing spondylitis functional index and the Dougados functional index in the assessment of ankylosing spondylitis. J Rheumatol 26:961–965PubMed
2.
go back to reference Vosse D, van der Heijde D, Landewé R, Geusens P, Mielants H, Dougados M, van der Linden S (2006) Determinants of hyperkyphosis in patients with ankylosing spondylitis. Ann Rheum Dis 65:770–774PubMedCrossRef Vosse D, van der Heijde D, Landewé R, Geusens P, Mielants H, Dougados M, van der Linden S (2006) Determinants of hyperkyphosis in patients with ankylosing spondylitis. Ann Rheum Dis 65:770–774PubMedCrossRef
3.
go back to reference Davis JC, Dougados M, Braun J, Sieper J, van der Heijde D, van der Linden S, for the ASAS (Assessment of Ankylosing Spondylitis) International Working Group (2006) The definition of disease duration in ankylosing spondylitis: reassessing the concept. Ann Rheum Dis 65:1518–1520PubMedCrossRef Davis JC, Dougados M, Braun J, Sieper J, van der Heijde D, van der Linden S, for the ASAS (Assessment of Ankylosing Spondylitis) International Working Group (2006) The definition of disease duration in ankylosing spondylitis: reassessing the concept. Ann Rheum Dis 65:1518–1520PubMedCrossRef
4.
go back to reference Schmidt KL, Schafer U (1982) Rehabilitationsprobleme bei der ankylosierenden Spondylitis. Akt Rheumatol 7 Sonderheft: 130–138 Schmidt KL, Schafer U (1982) Rehabilitationsprobleme bei der ankylosierenden Spondylitis. Akt Rheumatol 7 Sonderheft: 130–138
5.
go back to reference Feldtkeller E (1998) Unterschiede im Krankheitsverlauf männlicher und weiblicher Spondylarthritis-Patienten. Akt Rheumatol 23:145–153 Feldtkeller E (1998) Unterschiede im Krankheitsverlauf männlicher und weiblicher Spondylarthritis-Patienten. Akt Rheumatol 23:145–153
6.
go back to reference Feldtkeller E (1998) Rückgang von Spondylarthritis-Schmerzen nach langer Krankheitdauer begünstigt männliche Patienten. Akt Rheumatol 23:176–181CrossRef Feldtkeller E (1998) Rückgang von Spondylarthritis-Schmerzen nach langer Krankheitdauer begünstigt männliche Patienten. Akt Rheumatol 23:176–181CrossRef
7.
go back to reference Feldtkeller E (1999) Erkrankungsalter und Diagnoseverzögerung bei Spondylarthropathien. Z Rheumatol 58:21–30PubMedCrossRef Feldtkeller E (1999) Erkrankungsalter und Diagnoseverzögerung bei Spondylarthropathien. Z Rheumatol 58:21–30PubMedCrossRef
8.
go back to reference Feldtkeller E, Bruckel J, Khan MA (2000) Scientific contributions of ankylosing spondylitis patient advocacy groups. Curr Opin Rheumatol 12:239–247PubMedCrossRef Feldtkeller E, Bruckel J, Khan MA (2000) Scientific contributions of ankylosing spondylitis patient advocacy groups. Curr Opin Rheumatol 12:239–247PubMedCrossRef
9.
go back to reference Feldtkeller E, Khan MA, van der Heijde D, van der Linden S, Braun J (2003) Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatol Int 23:61–66PubMed Feldtkeller E, Khan MA, van der Heijde D, van der Linden S, Braun J (2003) Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatol Int 23:61–66PubMed
10.
go back to reference Feldtkeller E, Vosse D, Geusens P, van der Linden S (2006) Prevalence and annual incidence of vertebral fractures in patients with ankylosing spondylitis. Rheumatol Int 26:234–239PubMedCrossRef Feldtkeller E, Vosse D, Geusens P, van der Linden S (2006) Prevalence and annual incidence of vertebral fractures in patients with ankylosing spondylitis. Rheumatol Int 26:234–239PubMedCrossRef
11.
go back to reference Feldtkeller E, Hammel L, Kellner H (2005) Krankheitsaktivität und medikamentöse Therapie bei Spondylitis ankylosans—Ergebnisse einer Patientenbefragung. Akt Rheumatol 30:223–231CrossRef Feldtkeller E, Hammel L, Kellner H (2005) Krankheitsaktivität und medikamentöse Therapie bei Spondylitis ankylosans—Ergebnisse einer Patientenbefragung. Akt Rheumatol 30:223–231CrossRef
12.
go back to reference Feldtkeller E, Hammel L, Kellner H (2007) Aktuelle Trends in der Therapie der Spondylitis ankylosans—Ergebnisse einer Patientenbefragung. Akt Rheumatol (submitted) Feldtkeller E, Hammel L, Kellner H (2007) Aktuelle Trends in der Therapie der Spondylitis ankylosans—Ergebnisse einer Patientenbefragung. Akt Rheumatol (submitted)
13.
go back to reference Brophy S, Mackay K, Al-Saidi A, Taylor G, Calin A (2002) The natural history of ankylosing spondylitis as defined by radiological progression. J Rheumatol 29:1236–1243PubMed Brophy S, Mackay K, Al-Saidi A, Taylor G, Calin A (2002) The natural history of ankylosing spondylitis as defined by radiological progression. J Rheumatol 29:1236–1243PubMed
14.
go back to reference Zink A, Listing J, Klindworth C, Zeidler H, for the German Collaborative Arthritis Centers (2001) The national database of the German collaborative arthritis centres: I. Structure, aims, and patients. Ann Rheum Dis 60:199–206CrossRef Zink A, Listing J, Klindworth C, Zeidler H, for the German Collaborative Arthritis Centers (2001) The national database of the German collaborative arthritis centres: I. Structure, aims, and patients. Ann Rheum Dis 60:199–206CrossRef
Metadata
Title
Definition of disease duration in ankylosing spondylitis
Authors
Ernst Feldtkeller
Jon Erlendsson
Publication date
01-05-2008
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 7/2008
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-007-0499-y

Other articles of this Issue 7/2008

Rheumatology International 7/2008 Go to the issue